New YorkRelates to requiring Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for certain purposes
What it does
Relates to requiring Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for obesity, metabolic disorders, and autism-related compulsive eating behaviors.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jan 7REFERRED TO HEALTHLatest
- 2025
- Dec 19REFERRED TO HEALTHIntroduced